StockData

BioScience Health Innovations, Inc. (BHIC) stock

BHICOTCServices-Computer Processing & Data PreparationFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$6.78+0.00 (0.00%)

Close on Oct 16, 2026Market cap $79.22MP/E –Yield –

BioScience Health Innovations r&d expenses

Research and development expenses are spending on new products and technology.

BioScience Health Innovations's R&D Expenses for the twelve months ending Jun 30, 2026 was $234.88K. For fiscal 2025 it was $37.54K, up 44.9% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$37.54K+44.9%
FY2024Dec 31, 2024$25.91K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q2 FY2026CQ2 2026Jun 30, 2026$70.58K+663.6%
Q1 FY2026CQ1 2026Mar 31, 2026$49.72K+32.5%
Q4 FY2025CQ4 2025Dec 31, 2025$94.98K+265.1%
Q3 FY2025CQ3 2025Sep 30, 2025$19.59K+555.2%
Q2 FY2025CQ2 2025Jun 30, 2025$9.24K+1048.2%
Q1 FY2025CQ1 2025Mar 31, 2025$37.54K–
Q3 FY2024CQ3 2024Sep 30, 2024$26.01K–
Q2 FY2024CQ2 2024Jun 30, 2024$2.99K–
Q1 FY2024CQ1 2024Mar 31, 2024$805–

More BioScience Health Innovations figures

See a number that looks wrong?